Tim Sweeney, MD, PhD, is co-founder and CEO of Inflammatix. Tim has extensive experience in medical practice (general & trauma surgery), bench research, and bioinformatics / machine learning. While training at Stanford he helped invent the core technology on which Inflammatix is based. He’s named on over a dozen patents related to medical diagnostics, and has published >100 manuscripts & abstracts.  He is PI (through Inflammatix) on multiple development contracts from DARPA, BARDA, and NIH, and under his leadership, Inflammatix was recognized as the ‘Most Disruptive Technology’ at AACC in 2019 and placed on the “Fierce 15” list in 2020.

NDFS17 Inflammatix